Your browser doesn't support javascript.
loading
The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity.
Copple, Ian M; Goldring, Christopher E; Kitteringham, Neil R; Park, B Kevin.
Afiliação
  • Copple IM; MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, The University of Liverpool, Sherrington Building, Ashton Street, Liverpool, Merseyside L69 3GE, UK.
Handb Exp Pharmacol ; (196): 233-66, 2010.
Article em En | MEDLINE | ID: mdl-20020265
ABSTRACT
Adverse drug reactions pose a significant public health problem. In some cases, the process of drug metabolism can contribute to the onset of toxicity through the bioactivation of a parent molecule to a chemically reactive intermediate. In order to maintain a favorable balance between bioactivation and detoxification, mammalian cells have evolved an inducible cell defense system known as the antioxidant response pathway. The activity of this cytoprotective pathway is largely regulated by the transcription factor Nrf2, which governs the expression of many phase II detoxification and antioxidant enzymes. In turn, the activity of Nrf2 is regulated by the cysteine-rich cytosolic inhibitor Keap1, which acts as a "sensor" for chemical/oxidative stress. This article summarizes our current understanding of the molecular mechanisms that regulate the function of the Keap1-Nrf2 pathway and highlights the importance of Nrf2 in the protection against drug-induced toxicity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Peptídeos e Proteínas de Sinalização Intracelular / Hipersensibilidade a Drogas / Fator 2 Relacionado a NF-E2 Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2010 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Peptídeos e Proteínas de Sinalização Intracelular / Hipersensibilidade a Drogas / Fator 2 Relacionado a NF-E2 Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2010 Tipo de documento: Article